Medicine and Dentistry
Antiinfective Agent
100%
Tertiary Care
91%
COVID-19
59%
Bloodstream Infection
40%
Infection
38%
Retrospective Cohort Study
33%
Clostridium Difficile Infection
32%
Cohort Effect
28%
Odds Ratio
27%
Antibiotics
25%
Hand Hygiene
24%
Cross Sectional Study
24%
Surgical Infection
20%
Health Care
19%
Antimicrobial Therapy
18%
Observational Study
17%
Emergency Department
17%
Cholangitis
16%
Blood Culture
15%
Carbapenem
13%
Intensive Care Unit
12%
Fungemia
12%
Prevalence
11%
Bacterial Meningitis
10%
Syphilis
10%
Vaccine Hesitancy
9%
Time Series Analysis
8%
Consultation
8%
Infection Control
8%
Dentistry
8%
Vancomycin
8%
Neurology
8%
Gram-Negative Bacteria
8%
Ventilator-Associated Pneumonia
8%
Fusobacterium nucleatum
8%
Human Coronavirus OC43
8%
Coronavirinae
8%
Case-Control Study
8%
Topical Corticosteroid
8%
Retina Macula Cystoid Edema
8%
Cancer
8%
Systemic Candidiasis
8%
Central Nervous System Infection
8%
Hospital Management
8%
Mastitis
8%
Booster Dose
8%
Laparoscopic Surgery
8%
Immigrant
8%
Chorioretinitis
8%
Outpatient
8%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
81%
Infection
42%
Cohort Study
29%
Prevalence
25%
Clostridium Difficile Infection
24%
Vancomycin
24%
Bloodstream Infection
24%
Disease
22%
Surgical Infection
20%
Antibiotic Agent
19%
Antimicrobial Therapy
17%
Symptom
16%
Antibiotics
16%
Cross Sectional Study
16%
COVID-19 Vaccine
14%
Vaccination Policy
10%
Hospital Infection
10%
Cross-Sectional Study
9%
Prospective Cohort Study
8%
Methicillin Resistant Staphylococcus Aureus Infection
8%
Ventilator Associated Pneumonia
8%
Therapeutic Drug Monitoring
8%
Enterobacteriaceae
8%
Coronavirinae
8%
Metallo Beta Lactamase
8%
Invasive Candidiasis
8%
Case-Control Study
8%
Brain Abscess
8%
Cholangitis
8%
Observational Study
8%
Staphylococcal Bacteremia
8%
SARS Coronavirus
8%
Sarilumab
8%
Backache
8%
Fungemia
8%
Diseases
8%
All Cause Mortality
5%
Candidiasis
5%
Keyphrases
Japan
31%
Tertiary Care Hospital
29%
Retrospective Cohort Study
24%
Infectious Diseases Consultation
16%
Tokyo
13%
Audit-and-feedback
12%
Stewardship
12%
Fungemia
12%
Days of Therapy
10%
Surgical Antimicrobial Prophylaxis
10%
Syphilis
10%
Prospective Audit
9%
Interrupted Time Series
9%
Success Strategies
8%
Adjusted Odds Ratio
8%
Mandatory Policy
8%
Multifaceted Intervention
8%
Current Recommendations
8%
Oriental Cholangiohepatitis
8%
Blood Culture Collection
8%
National Survey in Japan
8%
Post-COVID-19
8%
Hospital Cluster
8%
Admission Screening
8%
Cholangitis
8%
Laparoscopic Surgery
8%
Barriers to Adherence
8%
Enterobacteriaceae
8%
Bloodstream Infection
8%
Actinomycosis
8%
Inpatient Setting
8%
Sustainability Assessment
8%
Cystoid Macular Edema
8%
Carbapenem Use
8%
Therapeutic Drug Monitoring
8%
Antimicrobial Stewardship
8%
Invasive Candidiasis
8%
Wrist
8%
Program Vector
8%
Children's Hospital
8%
Vector Autoregressive Model
8%
Antibiotic Spectrum
8%
Off Periods
8%
Antimicrobial Therapy
8%
Mastitis
8%
Hepatic Malignancy
8%
Metallo-β-lactamase
8%
Rapidly Growing Mycobacteria
8%
Hand Hygiene Practice
8%
COVID-19
8%
